News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
864,486 Results
Type
Article (87605)
Company Profile (823)
Press Release (776040)
Multimedia
Podcasts (181)
Webinars (28)
Section
Business (233134)
Career Advice (4140)
Deals (39823)
Drug Delivery (141)
Drug Development (91306)
Employer Resources (203)
FDA (18310)
Job Trends (17411)
News (397560)
Policy (39934)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (151)
Alzheimer's disease (1700)
Antibody-drug conjugate (ADC) (278)
Approvals (18361)
Artificial intelligence (539)
Autoimmune disease (116)
Automation (31)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (174)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (54)
Breast cancer (538)
Cancer (4311)
Cardiovascular disease (383)
Career advice (3562)
Career pathing (38)
CAR-T (262)
CDC (57)
Cell therapy (726)
Cervical cancer (33)
Clinical research (76044)
Collaboration (1486)
Company closure (4)
Compensation (996)
Complete response letters (64)
COVID-19 (2967)
CRISPR (88)
C-suite (654)
Cystic fibrosis (143)
Data (5239)
Decentralized trials (2)
Denatured (66)
Depression (122)
Diabetes (475)
Diagnostics (7126)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (253)
Drug pricing (197)
Drug shortages (36)
Duchenne muscular dystrophy (212)
Earnings (99781)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (133848)
Executive appointments (1003)
FDA (20962)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1337)
Gene editing (187)
Generative AI (53)
Gene therapy (587)
GLP-1 (1053)
Government (5401)
Grass and pollen (8)
Guidances (376)
Healthcare (20941)
HIV (51)
Huntington's disease (41)
IgA nephropathy (76)
Immunology and inflammation (267)
Immuno-oncology (23)
Indications (61)
Infectious disease (3223)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (203)
Interviews (816)
IPO (17934)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (86)
Layoffs (649)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (14)
Lung cancer (609)
Lymphoma (300)
Machine learning (33)
Management (66)
Manufacturing (684)
MASH (160)
Medical device (14929)
Medtech (14961)
Mergers & acquisitions (22824)
Metabolic disorders (1237)
Multiple sclerosis (144)
NASH (23)
Neurodegenerative disease (245)
Neuropsychiatric disorders (75)
Neuroscience (2817)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (593)
Opinion (318)
Ovarian cancer (148)
Pain (174)
Pancreatic cancer (186)
Parkinson's disease (249)
Partnered (32)
Patents (440)
Patient recruitment (354)
Peanut (58)
People (66433)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23458)
Phase II (33004)
Phase III (24879)
Pipeline (3343)
Policy (310)
Postmarket research (3554)
Preclinical (10601)
Press Release (72)
Prostate cancer (211)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (726)
Real estate (7427)
Recruiting (80)
Regulatory (28237)
Reports (65)
Research institute (2702)
Resumes & cover letters (651)
Rett syndrome (20)
RNA editing (16)
RSV (78)
Schizophrenia (144)
Series A (219)
Series B (166)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (96)
The Weekly (113)
Vaccines (1074)
Venture capital (71)
Weight loss (414)
Women's health (67)
Worklife (21)
Date
Today (124)
Last 7 days (836)
Last 30 days (3815)
Last 365 days (33485)
2025 (30022)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1286)
Alabama (83)
Alaska (7)
Arizona (315)
Arkansas (14)
Asia (51137)
Australia (8991)
California (10299)
Canada (3014)
China (977)
Colorado (434)
Connecticut (461)
Delaware (295)
Europe (117613)
Florida (1501)
Georgia (334)
Hawaii (3)
Idaho (68)
Illinois (847)
India (57)
Indiana (498)
Iowa (20)
Japan (346)
Kansas (129)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1359)
Massachusetts (7666)
Michigan (328)
Minnesota (602)
Mississippi (6)
Missouri (128)
Montana (33)
Nebraska (26)
Nevada (111)
New Hampshire (81)
New Jersey (2827)
New Mexico (32)
New York (2750)
North Carolina (1480)
North Dakota (10)
Northern California (4790)
Ohio (315)
Oklahoma (22)
Oregon (51)
Pennsylvania (2111)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (54)
South Dakota (1)
Southern California (3942)
Tennessee (157)
Texas (1605)
United States (37596)
Utah (308)
Virginia (261)
Washington D.C. (85)
Washington State (864)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
There are 864,486 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
J&J, Aiming for $50B in Cancer Sales, Buys Halda for $3B in Cash
Halda Therapeutics is developing oral assets for prostate and lung cancer. The deal comes after Johnson & Johnson set an ambitious goal for its oncology sales by 2030.
November 17, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
OS Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
November 17, 2025
·
8 min read
Press Releases
Adaptimmune Announces Changes to Board and Executive Leadership Team
November 17, 2025
·
7 min read
Press Releases
Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
November 17, 2025
·
6 min read
Press Releases
Theralase(R) Investor Conference Call Reminder
Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete Response
November 17, 2025
·
5 min read
Press Releases
Scryb Highlights New U.S. Institutional Fund Investment in Cybeats; Strengthens Long-Term Outlook
November 17, 2025
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress
Presenting INTASYL siRNA Drug Technology
November 17, 2025
·
3 min read
Press Releases
PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program
November 17, 2025
·
7 min read
Collaboration
Lilly Bets More Than $2.6B For South Korea Biotech’s Bispecific Antibody Platform
The companies have yet to disclose how many programs they plan to collaborate on or what indications they will prioritize.
November 17, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Imposes Boxed Warning, Narrows Patient Pool for Sarepta’s Duchenne Gene Therapy Elevidys
Sarepta must also run a post-marketing study for Elevidys to better assess the risk of serious liver injury in patients dosed with the gene therapy.
November 17, 2025
·
1 min read
·
Tristan Manalac
1 of 86,449
Next
